Catalyst Wire Dossier Catalyst Wire Dossier

Desvenlafaxine succinate sustained-release (DVS SR) 100 mg

desvenlafaxine succinate sustained-release · Pfizer
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Desvenlafaxine succinate sustained-release (DVS SR) 100 mg, covering 2011-10-17 to 2011-10-17. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Aripiprazole When Coadministered To Healthy Subjects [Phase 4]

See pricing